glp 1 agonist in heart failure JCI The cardiovascular effects of GLP-1
Description
Zhou, Q
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
Proponents claim it's the miracle weight loss pill the world has been waiting for
How can clinicians manage these interactions
The inclusion/exclusion process is shown in Fig
